Cystatin C as prognostic biomarker in ST-segment elevation acute myocardial infarction

American Journal of Cardiology

Volumn 109, Issue 10, 2012, Pages 1431-1438

  Silva, Doroteia ^a   Cortez Dias, Nuno ^a,b,c   Jorge, Cláudia ^a   Marques, J Silva ^a   Carrilho Ferreira, Pedro ^a   Magalhães, Andreia ^a   Martins, Susana R ^a,b   Gonçalves, Susana ^a   Da Silva, Pedro Canas ^a   Fiúza, Manuela ^a,b   Diogo, António Nunes ^a,b   Pinto, Fausto J ^a,b  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c Programme for Advanced Medical Education   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; CYSTATIN C;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; DEATH; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HAZARD RATIO; HEART LEFT VENTRICLE EJECTION FRACTION; HEART REINFARCTION; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY FUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CYSTATIN C; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84860434853     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.01.356     Document Type: Article

References (18)

1. O.F. Laterza, C.P. Price, M.G. Scott Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 48 2002 699 707
2. A. Shimizu-Tokiwa, M. Kobata, H. Io, N. Kobayashi, I. Shou, K. Funabiki, M. Fukui, S. Horikoshi, I. Shirato, K. Saito, Y. Tomino Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine Nephron 92 2002 224 226
3. A.P. Antoniadis, Y.S. Chatzizisis, G.D. Giannoglou Pathogenetic mechanisms of coronary ectasia Int J Cardiol 130 2008 335 343
4. C. Ge, F. Ren, S. Lu, F. Ji, X. Chen, X. Wu Clinical prognostic significance of plasma cystatin C levels among patients with acute coronary syndrome Clin Cardiol 32 2009 644 648
5. T. Barka, H. van der Noen Expression of the cysteine proteinase inhibitor cystatin C gene in rat heart: use of digoxigenin-labeled probes generated by polymerase chain reaction directly for in situ and northern blot hybridizations J Histochem Cytochem 41 1993 1863 1867
6. T. Jernberg, B. Lindahl, S. James, A. Larsson, L.O. Hansson, L. Wallentin Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome Circulation 110 2004 2342 2348
7. E. Ichimoto, K. Jo, Y. Kobayashi, T. Inoue, Y. Nakamura, N. Kuroda, A. Miyazaki, I. Komuro Prognostic significance of cystatin C in patients with ST-elevation myocardial infarction Circ J 73 2009 1669 1673
8. H.L. Hillege, A.R. Girbes, P.J. de Kam, F. Boomsma, D. de Zeeuw, A. Charlesworth, J.R. Hampton, D.J. van Veldhuisen Renal function, neurohormonal activation, and survival in patients with chronic heart failure Circulation 102 2000 203 210
9. A. Al-Ahmad, W.M. Rand, G. Manjunath, M.A. Konstam, D.N. Salem, A.S. Levey, M.J. Sarnak Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction J Am Coll Cardiol 38 2001 955 962
10. C. Ronco, P. McCullough, S.D. Anker, I. Anand, N. Aspromonte, S.M. Bagshaw, R. Bellomo, T. Berl, I. Bobek, D.N. Cruz, L. Daliento, A. Davenport, M. Haapio, H. Hillege, A.A. House, N. Katz, A. Maisel, S. Mankad, P. Zanco, A. Mebazaa, A. Palazzuoli, F. Ronco, A. Shaw, G. Sheinfeld, S. Soni, G. Vescovo, N. Zamperetti, P. Ponikowski Acute Dialysis Quality Initiative (ADQI) Consensus Group Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative Eur Heart J 31 2010 703 711
11. Y. Iwanaga, S. Miyazaki Cystatin C in a high-risk combination Circ J 73 2009 1593 1594
12. C. Ronco, M. Haapio, A.A. House, N. Anavekar, R. Bellomo Cardiorenal syndrome J Am Coll Cardiol 52 2008 1527 1539
13. P.C. Patel, C.R. Ayers, S.A. Murphy, R. Peshock, A. Khera, J.A. de Lemos, J.A. Balko, S. Gupta, P.P. Mammen, M.H. Drazner, D.W. Markham Association of cystatin C with left ventricular structure and function: the Dallas heart study Circ Heart Fail 2 2009 98 104
14. S. Gupta, M.H. Drazner, J.A. de Lemos Newer biomarkers in heart failure Heart Fail Clin 5 2009 579 588
15. J.H. Ix, M.G. Shlipak, G.M. Chertow, M.A. Whooley Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the heart and soul study Circulation 115 2007 173 179
16. M.G. Shlipak, M.J. Sarnak, R. Katz, L.F. Fried, S.L. Seliger, A.B. Newman, D.S. Siscovick, C. Stehman-Breen Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med 352 2005 2049 2060
17. J. Mares, D. Stejskal, J. Vavrouskova, K. Urbanek, R. Herzig, P. Hlustik Use of cystatin C determination in clinical diagnostics Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147 2003 177 180
18. T. Kilic, G. Oner, E. Ural, Z. Yumuk, T. Sahin, U. Bildirici, E. Acar, U. Celikyurt, G. Kozdag, D. Ural Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome Atherosclerosis 207 2009 552 558